Literature DB >> 22809746

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Hani Jneid, Jeffrey L Anderson, R Scott Wright, Cynthia D Adams, Charles R Bridges, Donald E Casey, Steven M Ettinger, Francis M Fesmire, Theodore G Ganiats, A Michael Lincoff, Eric D Peterson, George J Philippides, Pierre Theroux, Nanette K Wenger, James Patrick Zidar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22809746     DOI： 10.1016/j.jacc.2012.06.004

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  148 in total

Review 1.  Balancing ischaemia and bleeding risks with novel oral anticoagulants.

Authors:  Usman Baber; Ioannis Mastoris; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

Review 2.  Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs.

Authors:  Isobel Ford
Journal:  Ther Adv Drug Saf       Date:  2015-08

Review 3.  The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review.

Authors:  Jaya Chandrasekhar; Benjamin Hibbert; Michael Froeschl; Derek So; Roxana Mehran; Michel Le May
Journal:  Eur J Clin Pharmacol       Date:  2015-10-09       Impact factor: 2.953

4.  P2Y12 inhibition in patients with NSTEMI--can later be better?

Authors:  John F Keaney
Journal:  N Engl J Med       Date:  2013-09-01       Impact factor: 91.245

5.  Pharmacogenetic testing: Current Evidence of Clinical Utility.

Authors:  Jivan Moaddeb; Susanne B Haga
Journal:  Ther Adv Drug Saf       Date:  2013-08-01

Review 6.  Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerations.

Authors:  William S Weintraub; Leonid Mandel; Sandra A Weiss
Journal:  Pharmacoeconomics       Date:  2013-11       Impact factor: 4.981

7.  ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons.

Authors:  Manesh R Patel; John H Calhoon; Gregory J Dehmer; James Aaron Grantham; Thomas M Maddox; David J Maron; Peter K Smith
Journal:  J Nucl Cardiol       Date:  2017-04       Impact factor: 5.952

8.  Leucocytoclastic vasculitis as a late complication of clopidogrel therapy.

Authors:  Ranjan K Shetty; Mohit Madken; Kushal Naha; G Vivek
Journal:  BMJ Case Rep       Date:  2013-01-17

Review 9.  Monitoring aspirin and clopidogrel response: testing controversies and recommendations.

Authors:  Athanasios Karathanos; Tobias Geisler
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

Review 10.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.